CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

CAT

901.64

-1.14%↓

294.86

-0.88%↓

GEV.US

1,062.71

-0.85%↓

RTX

178.16

-0.31%↓

240.61

+1.55%↑

Kodu・Aktsiate loetelu・CryoPort Inc

CryoPort Inc

Suletud

SektorTööstus

13.24 1.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.96

Max

13.46

Põhinäitajad
By Trading Economics
Sissetulek	14M -9.4M
Müük	2.3M 48M
Aktsiakasum	-0.189
Kasumimarginaal	-19.733
Töötajad	684
EBITDA	443K -3.2M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+4.14% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. aug 2026

Turustatistika
By TradingEconomics
Turukapital	143M 664M
Eelmine avamishind	11.71
Eelmine sulgemishind	13.24

Uudiste sentiment

By Acuity

20%

80%

45 / 405 Pingereas Industrials

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

5.615 / N/A Toetus ja vastupanu

CryoPort Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. mai 2026, 22:50 UTC

Tulu

Commonwealth Bank of Australia Increases Provisions as 3Q Profit Slips

12. mai 2026, 22:49 UTC

Tulu

Aristocrat Leisure Raises Midyear Dividend, Swells Share Buyback Program

12. mai 2026, 22:32 UTC

Tulu

JBS 1Q Profit Slides Amid Rising Cattle Costs -- Update

12. mai 2026, 23:48 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Conflict -- Market Talk

12. mai 2026, 22:57 UTC

Market Talk

Tulu

JBS Says Consumers Are Looking to Pork for Affordable Protein -- Market Talk

12. mai 2026, 22:26 UTC

Tulu

Aristocrat Leisure to Increase On-Market Share Buyback by A$1 Billion

12. mai 2026, 22:25 UTC

Tulu

Aristocrat Leisure 1H Normalized Pretax Profit A$997.3 Million, Up 9.4% on Year

12. mai 2026, 22:25 UTC

Tulu

Aristocrat Leisure Interim Dividend A$0.50/Security

12. mai 2026, 22:24 UTC

Tulu

Aristocrat Leisure 1H Revenue From Continuing Operations A$3.03 Billion, Down 0.2% on Year

12. mai 2026, 22:23 UTC

Tulu

Aristocrat Leisure 1H Net Profit From Discontinued Operations A$7.0 Million

12. mai 2026, 22:23 UTC

Tulu

Aristocrat Leisure 1H Net Profit From Continuing Operations A$798.5 Million, Up 56%

12. mai 2026, 22:19 UTC

Tulu

CBA: Total Provision Coverage Ratio 1.57%>CBA.AU

12. mai 2026, 22:14 UTC

Tulu

CBA: Business Lending Continued to Grow Above System>CBA.AU

12. mai 2026, 22:14 UTC

Tulu

CBA Had 1.4M Business Transaction Accounts at March 31, Up 7% on Year>CBA.AU

12. mai 2026, 22:13 UTC

Tulu

CBA Household Deposits Grew A$38B in 12 Months Through March>CBA.AU

12. mai 2026, 22:12 UTC

Tulu

CBA Home Loan Balances Grew A$41B in 12 Months Through March>CBA.AU

12. mai 2026, 22:12 UTC

Tulu

CBA 3Q New Home Loan Funding A$45B>CBA.AU

12. mai 2026, 22:11 UTC

Tulu

Correct: JBS NV 1Q EPS 20c, Not 21c >JBS

12. mai 2026, 22:11 UTC

Tulu

CBA: CET1 Level 2 Capital Ratio 11.6%>CBA.AU

12. mai 2026, 22:10 UTC

Tulu

CBA: Customer Deposit Funding Ratio 79%>CBA.AU

12. mai 2026, 22:09 UTC

Tulu

CBA: Underlying Portfolio Credit Quality Remains Sound>CBA.AU

12. mai 2026, 22:09 UTC

Tulu

CBA: Higher Collective Provisions Reflect Geopolitical, Macroeconomic Uncertainty >CBA.AU

12. mai 2026, 22:08 UTC

Tulu

CBA 3Q Loan Impairment Expense A$316M>CBA.AU

12. mai 2026, 22:07 UTC

Tulu

CBA: Costs Up on Higher Cloud Computing Volumes, Software Licenses, AI Investment>CBA.AU

12. mai 2026, 22:06 UTC

Tulu

CBA 3Q Operating Expenses Up 1% Excluding Restructuring, Notable Items>CBA.AU

12. mai 2026, 22:06 UTC

Tulu

CBA: 3Q Underlying Net Interest Margin Was Broadly Stable>CBA.AU

12. mai 2026, 22:05 UTC

Tulu

CBA: Lending, Deposit Volume Growth Offset Impact of Two Fewer Days >CBA.AU

12. mai 2026, 22:04 UTC

Tulu

Commonwealth Bank: Operating Income Flat in March Quarter >CBA.AU

12. mai 2026, 22:04 UTC

Tulu

Commonwealth Bank 3Q Cash Profit Up 4% on Year>CBA.AU

12. mai 2026, 22:04 UTC

Tulu

Commonwealth Bank 3Q Cash Profit Down 1% on 1H Quarterly Average>CBA.AU

Võrdlus sarnastega

Hinnamuutus

CryoPort Inc Prognoos

Hinnasiht

By TipRanks

4.14% tõus

12 kuu keskmine prognoos

Keskmine 13.58 USD 4.14%

Kõrge 17 USD

Madal 9.5 USD

Põhineb 7 Wall Streeti analüütiku instrumendi CryoPort Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi CryoPort Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

5.615 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

There is one bullish event.

Sentiment

By Acuity

45 / 405 Pingereas Tööstus

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.